Chemical compound
Pharmaceutical compound
ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of “female genital diseases” and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.[1]
References
- ^ “ORG 201745 – AdisInsight”. adisinsight.springer.com.